Search

everythinglearnresearchcommunity

for

Search:↓

Baricitinib was effective in regrowing eyebrow and eyelash hair in patients with severe alopecia areata.

Increasing the dose of baricitinib to 4 mg helps more patients with severe alopecia areata regrow hair.

The demineralized bone matrix scaffold is better for cell attachment than the mineralized bone allograft.

A woman's hair grew back with baricitinib treatment, but she developed a temporary hairy tongue that was treated with regular tongue brushing.

Baricitinib is effective and safe for severe alopecia areata, working similarly with or without an atopic background.

Baricitinib is effective as a treatment for severe hair loss.

Baricitinib can cause excessive hair growth.

Baricitinib is a safe and effective treatment for severe alopecia areata.

Reducing the dose of Baricitinib to 2mg led to a loss of hair regrowth benefits in nearly half of the patients by Week-104.

The new drug delivery system improves bicalutamide skin retention for better treatment of hair loss.

Better diagnosis and control of thallium poisoning are needed to prevent severe outcomes.

Ca 45 mainly enters rat skin and eye through biosynthesis and may be adsorbed in cartilage and glands.

The study found that baicalin has different stable shapes in gas and water, with two shapes better for interacting with positive charges in water.

Baricitinib maintains significant hair regrowth in severe alopecia areata over three years.

Baricitinib 4 mg is effective and safe for treating severe alopecia areata.

Baricitinib, a medication taken by mouth, was effective in regrowing hair for people with severe hair loss.

Baricitinib is generally safe for long-term use in treating severe alopecia areata.

Baricitinib may effectively treat both alopecia areata and immune thrombocytopenia.

Oral baricitinib is effective and safe for treating alopecia areata.

Reducing the dose of Baricitinib to 2mg still helped over half of the patients with severe scalp alopecia maintain their hair regrowth after two years.

Baricitinib effectively treats severe alopecia for up to 104 weeks.

Baricitinib was effective in treating alopecia areata in two major trials.

Baricitinib significantly improved hair regrowth and quality of life in severe alopecia areata patients.

The new composite material is safe and has anticoagulant properties.

Baricitinib is effective and safe for treating severe alopecia areata.

Baricitinib treatment for alopecia universalis can cause hair regrowth with unexpected whitening.

A man was poisoned with thallium, treated successfully, but still had some nerve issues after 6 months.